Tian Tu Capital Co Ltd (01973.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 9Sep 14Sep 18

Key dataSep 18, 2026

OpenHKD 1.90

From 52W high−47.66%

Volume800.00

Market capHKD 1.31B

P/E (TTM)5.9x

P/S (TTM)1.0x

Div yield—

Key dataSep 18, 2026

Open

HKD 1.90

From 52W high

−47.66%

Volume

800.00

Market cap

HKD 1.31B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.1x

P/E (TTM)

5.9x

RSI (14)

48.3

MomentumView details →

1D Return

+5.85%

YTD Return

−47.66%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

5.9x

EV/EBITDA

−1.1x

EV/Sales

−0.2x

P/S (TTM)

1.0x

P/B (TTM)

0.2x

ProfitabilityView details →

Gross Margin

92.03%

Net Margin

18.02%

EBITDA Margin

15.07%

ROE (TTM)

2.95%

ROA (TTM)

1.54%

Asset Turnover

0.09x

GrowthView details →

Revenue YoY

+438.14%

EPS YoY

+348.55%

FCF YoY

+48.96%

Revenue CAGR 3Y

−65.64%

EPS CAGR 3Y

−29.82%

EBITDA YoY

+136.75%

MomentumView details →

1D Return

+5.85%

YTD Return

−47.66%

1Y Return

−39.30%

RSI (14)

48.3

vs 50D SMA

−6.54%

vs 200D SMA

−23.95%

Capital & dividendView details →

Debt/Equity

0.08x

Current Ratio

2.91x

Quick Ratio

2.91x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

HKD 0.24

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.07B

Net Income (TTM)

192.72M

Op. CF (TTM)

943.52M

Next earningsApr 6, 2027 →

Latest newsMore news →

Zhejiang Qilin Zhengwei Medical Technology Co., Ltd. (KylinWay), a hydrogen molecule anti-aging new materials company, completed a Series A financing of tens of millions of RMB, led by the Meili Linghang Fund under Tiantu Investment.18d ago

Tiantu Capital proposed an interim dividend of 0.15 RMB per share.24d ago

Similar companies

Virtus Ceredex Mid-Cap Value Equity ISMVTX Boston Partners All-Cap Value Fd Insti ClassBPAIX Cohen & Steers Global Realty ICSSPX Principal MidCap S&P 400 Index Fund;R-5PMFPX Fundrise Growth Tech Fund, LLCVCX Calvert Balanced CCSGCX Find similar companies →

Latest newsMore news →

Zhejiang Qilin Zhengwei Medical Technology Co., Ltd. (KylinWay), a hydrogen molecule anti-aging new materials company, completed a Series A financing of tens of millions of RMB, led by the Meili Linghang Fund under Tiantu Investment.18d ago Tiantu Capital proposed an interim dividend of 0.15 RMB per share.24d ago Tiantu Capital reported interim results for the six months ended June 2026, with net profit of 72.235 million RMB, down 4.96% year-on-year, and revenue of 2.442 million RMB, down 82.8%.24d ago